Previous Close | 0.9000 |
Open | 0.9000 |
Bid | 0.0000 |
Ask | 1.4000 |
Strike | 30.00 |
Expire Date | 2024-10-18 |
Day's Range | 0.9000 - 0.9000 |
Contract Range | N/A |
Volume | |
Open Interest | 2 |
CAMBRIDGE, Mass., May 14, 2024--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, today announced it will host an Investor Day on Wednesday, May 22, 2024 beginning at 8:30 a.m. ET in New York City.
Exploring the Financial Landscape and Strategic Progress Amidst Challenges
CAMBRIDGE, Mass., May 07, 2024--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, today reported financial results and corporate updates for the first quarter ended March 31, 2024.